***** TODAY’S NEWS AstraZeneca still waiting for the upside of MedImmune acquisition. Pfizer: More Lipitor, fewer heart complications - A reanalysis of research data found a high dose of popular …
Pharma News 1_26
Daiichi-Sankyo's Welchol gets approval for improving glycemic control in adults with Type 2 diabetes. Novartis - for 11 years in a row - grabs the top spot in the Verispan Managed Care audit. Roche …
Cholesterol – good, bad, and indifferent
What a week it was for cholesterol! It was Lipidemia Rollercoaster - here's a summary. First, the kerfuffle with Vytorin. As you have probably heard, Merck and Schering-Plough have been roundly …
Continue Reading about Cholesterol – good, bad, and indifferent →
Pharma News 1_04
So, who is getting all those free drug samples, anyway? The poor, or the wealthy insured? A recent study puts this to the test. Some refreshing candor - Novartis CEO Dan Vasella admits that he uses …
Big Pharma – Hitting a Wall?
From today's Wall Street Journal (subscription may be required) Over the next few years, the pharmaceutical business will hit a wall. Some of the top-selling drugs in industry history will become …